by Pharmacy Podcast Network
One of the most common definitions of pain describes pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” When we are exposed to something that causes pain, if able, we quickly or reflexively withdraw. The sensory feeling of pain is called nociception. Our Host: Mark Garofoli, PharmD Clinical Assistant Professor WVU School of Pharmacy (Department of Clinical Pharmacy) WV School of Pharmacy curriculum education in areas of expertise such as pain management, substance-use disorder, medication therapy management, managed care, geriatric care, management, leadership, and experiential learning.
Language
🇺🇲
Publishing Since
3/2/2021
Email Addresses
0 available
Phone Numbers
0 available
March 11, 2025
This episode of the Pain Pod takes a moment to sit down with THE Pharmacist Athlete, Dr. Brandon Welch!What is sports pharmacy? Patient athletes? Where does a pharmacist fit into sports teams? All of this and much, much more. Perhaps even a little inspiration to figure out your dreams and live them out!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.usPharmacy Athlete• https://pharmacyathlete.com/
February 17, 2025
Extra Extra, Read all about it! Actually, it’s a podcast, Listen all about it! New Pain Med! New Pain Med! New Non-Opioid Pain Med!Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it?????We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod!Come one, come all, to the Pain Pod!!!Pain Guy• www.painguy.us
January 29, 2025
Clinical Pearls, Pain Pod edition: Pain Pearls Part 1 (of many)!A cornucopia of pain conundrums and potential solutions and/or tools to help mitigate. All here, nicely packaged, randomly, in one episode of the Pain Pod! One of many more to come, in a miniseries titled: “Pain Pearls”, only here on the Pain Pod!Come one, come all, to the Pain Pod!!!P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us to directly reach Mark and have your voice heard!Pain Guy• www.painguy.usDVPRS (Pain Scale)• https://www.va.gov/PAINMANAGEMENT/docs/DVPRS_2slides_and_references.pdf Opioid Risk Screenings• www.opioidrisk.com 2022 CDC Opioid Guideline Update• Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95.Buprenorphine Induction Resources• Kampman K and Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. Sep-Oct 2015;9(5):358-67.• Ahmed, S. Bhivandkar S, et. al. Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions, 30: 305–315, 2021.• Privia A. Randhawa, Rupinder Brar and Seonaid Nolan. Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market CMAJ January 20, 2020 192 (3) E73.MOUD Minimum Durations Study• Michael L. Dennis, Mark A. Foss, and Christy K. Scott. An Eight-Year Perspective on the Relationship Between the Duration of Abstinence and Other Aspects of Recovery. Evaluation Review 2007 31:6, 585-612
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
